Clovis Oncology Inc (NASDAQ:CLVS)

5.62
Delayed Data
As of May 13
 -0.09 / -1.58%
Today’s Change
4.08
Today|||52-Week Range
11.10
+17.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues22.8M30.4M33.1M33.0M
 
 
 
 
 
Cost of Goods Sold4.5M4.9M6.8M5.8M
 
 
 
 
 
Depreciation And Amortization990.0K2.1M1.7M1.9M
 
 
 
 
 
 
Operating ExpensesGross Income17.2M23.4M24.6M25.3M
 
 
 
 
 
General Expenses106.4M120.4M109.8M118.8M
 
 
 
 
 
Research And Development63.9M71.2M62.0M70.7M
 
 
 
 
 
Total Operating Expenses111.9M127.3M118.3M126.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-89.2M-97.0M-85.2M-93.5M
 
 
 
 
 
Extraordinary Charge0.000.000.00-25.0M
 
 
Interest Expense On Debt3.4M3.6M3.6M3.8M
 
 
 
 
 
Other Expenses2.7M2.2M2.2M1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-89.9M-98.4M-86.6M-120.6M
 
 
 
 
 
Income Taxes-13.0K-888.0K-160.0K-176.0K
 
 
 
 
 
Net Income-89.9M-99.3M-86.4M-120.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.7M52.7M52.9M53.0M
 
 
 
 
 
Shares To Calculate EPS Diluted52.7M52.7M52.9M53.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.71-$1.88-$1.63-$2.27
 
 
 
 
 
EPS Diluted-$1.71-$1.88-$1.63-$2.27